Nanobiotix offers upside via broad radiotherapy platform adoption but faces clinical, operational, and dilution risks. Read ...

Is CCI a good stock to buy? We came across a bullish thesis on Crown Castle Inc. on The Mispricing Desk’s Substack. In this ...

The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 ...

During the Archean Eon—roughly 4 billion years ago—the Earth was a lifeless planet. The atmosphere lacked oxygen, and there ...

Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association ...

Broad-spectrum antibiotic use before and after CAR T correlates with worse overall survival and increased neurotoxicity, although confounding exists because antibiotics cluster with cytokine release ...

Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...

China is on track to set a new record for solar power installations in 2024, driven by falling production costs and increased ...

An experimental treatment that resets a malfunctioning immune system has put the disease lupus into remission in early UK ...

Three-year RP data showed durable efficacy: intravitreal AAV2 optogenetics improved ~3 ETDRS lines, while lentiviral PEDF ...

A Cambridge biotech company is laying off 85% of staff and ending its sickle cell drug after the FDA cited unacceptable ...